Sonoran Biosciences, an early stage pharmaceutical company spun out of Arizona State University, has received a $1.48 million research grant for its antibiotic gel to treat prosthetic joint infections.

Sonoran Biosciences was founded by a team led by Derek Overstreet, who worked in Associate Professor Brent Vernon’s Biomaterials Lab while earning his doctoral degree in biomedical engineering at ASU.  Overstreet remains an adjunct professor in the School of Biological and Health Systems Engineering.